joimax obtained full product registration from the Thai Food & Drug Administration. Certification in Japan, Malaysia and Taiwan is expected during 2017.
Results of evaluation of MicroPort Orthopedics’ Medial Pivot Knee demonstrated 95.0% satisfaction and 98.8% survivorship at 17 years, with patients reporting high stability and comfort during regular activity.
Independent study results indicate that mean wear associated with Amedica’s MC2® silicon nitride femoral heads was ~15% lower than a BIOLOX®delta sample after five million cycles.
Tissue Regenix plans a 2018 launch for dCELL® decellularization technology in the U.S. for orthopaedic applications, initially addressing ACL repair.Â
Our site uses cookies to allow easier access for Members and subscribers and to improve our site. You agree to our use of cookies by closing this message box or continuing to use our site.OkRead more